Humanity’s List

Research with real-world weight.

Vol. I · No. 30Updated UTC
Ranked by formula

Top stories

  1. MedicineEurope PMC

    1. 14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan

    Trifluridine-tipiracil (FTD-TPI) plus bevacizumab is the standard treatment for refractory metastatic colorectal cancer.

    Verdict: Major█████░░░░░4.9
  2. AIarXiv

    2. Factorized Gradients for Scalable Highly-expressive Parametric Diffeomorphisms

    Diffeomorphisms provide a flexible, topology-preserving mathematical tool for modeling complex spatial or temporal deformations and are used in various scientific fields.

    Verdict: Major█████░░░░░4.9
  3. AIarXiv

    3. Lipi-Ghor: A Large-Scale, Diarized, Multi-Domain Bengali Speech Corpus and a Scalable Pipeline for Building It

    Bengali, spoken by over 230 million people, remains severely under-resourced in spoken language research.

    Verdict: Notable█████░░░░░4.9
  4. BiologybioRxiv

    4. Design of full-length agonist and antagonist antibodies for hard targets

    Verdict: Notable█████░░░░░4.7
  5. PhysicsarXiv

    5. Universal Scaling of the Little-Parks Oscillation Amplitude

    Verdict: Notable█████░░░░░4.6
  6. PhysicsarXiv

    6. An Intermediate Mass Stripped Star in a 4.2-hour Orbit around a Compact Object

    Verdict: Notable█████░░░░░4.6

Sections

arXiv

DynaFlow: Learning Free-Form Multi-Agent Orchestration

Multi-agent systems often rely on predefined collaboration structures, limiting their ability to adapt to diverse task requirements.

By Liu, Li, Wang +1

Verdict: Notable██████░░░░5.8
  • HF ▲ 189
  • Stars ★ 53

Europe PMC

Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer

The combination of docetaxel, trastuzumab, and pertuzumab (THP) is an established first-line treatment for human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer.

By Wang, Li, Xu +39The New England journal of medicine

Verdict: Major█████░░░░░5.4
  • Cites 1

News

Briefs